Andrew Albert Kucharchuk - 30 May 2025 Form 4 Insider Report for CERO THERAPEUTICS HOLDINGS, INC. (CERO)

Role
Chief Financial Officer
Signature
/s/ Chris Ehrlich, Attorney-in-Fact
Issuer symbol
CERO
Transactions as of
30 May 2025
Net transactions value
$0
Form type
4
Filing time
02 Jun 2025, 16:57:58 UTC
Previous filing
02 Oct 2024
Next filing
05 Aug 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
KUCHARCHUK ANDREW ALBERT Chief Financial Officer CERO THERAPEUTICS HOLDINGS, INC., 201 HASKINS WAY, SUITE 230, SOUTH SAN FRANCISCO /s/ Chris Ehrlich, Attorney-in-Fact 02 Jun 2025 0001654127

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CERO Stock Option (Right to Buy) Award $0 +152,500 $0.000000 152,500 30 May 2025 Common Stock 152,500 $0.4454 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying this option shall vest in equal monthly installments through June 4, 2027.